Omadacycline - Indications, Pharmacology, Warnings, and Precautions

Overview:

Omadacycline is quite a novel medicament with antibacterial effects. It is an aminomethylcycline antibacterial that is semisynthetic and is structurally a tetracycline derivative. This semisynthetic antibacterial was licensed for acute bacterial skin and skin structure infections by the United States Food and Drug Administration (USFDA) in 2018. Omadacycline is expressly noted for its activity against resistant organisms and is tolerant to other conventional antibacterial drug choices. In addition to Omadacycline’s use in acute bacterial skin and skin structure infection, there is another therapeutic application for it: community-acquired bacterial pneumonia (CABP).

Drug Group:

Tetracycline antibiotic is the drug group in which Omadacycline is included. These have a broader spectrum and coverage against multiple bacterial subtypes. Most of these tetracycline antibiotics inhibit and interrupt the protein synthesis in bacteria to check bacterial growth.

Available Doses and Dosage Forms:

Omadacycline injection and tablet are both forms of therapeutic use. Regarding the available doses, Omadacycline is given as 100 milligrams of lyophilized powder and 150 milligrams of pills; the first is for injection, and the second is for oral consumption.

For Patients:

How Does Omadacycline Work for Acute Bacterial Skin and Skin Structure Infections?

Acute bacterial skin and skin structure infections, or the synonym ABSSSI, is an umbrella phrase that includes several bacterial infections in the skin or its associated structures. Antibacterial therapy is the key therapy for acute bacterial skin and skin structure infections. However, the choice of antimicrobials does vary with the infection type and the bacteria involved. Therefore, the antibacterial regimen has to be chosen accordingly. Bacterial resistance to these antibacterial medicines is the main problem that tends to complicate the treatment of these conditions. There comes the role of Omadacycline as it is capable to overcome and bypass the bacterial resistance.

Omadacycline potentially interrupts and blocks the process of protein synthesis in bacterial cells. Without protein synthesis, the bacteria will have trouble growing and expanding their colony. Bacteriostatic properties, which means the medicine is capable of holding bacterial growth, are displayed by the Omadacycline. On the other hand, bactericidal properties, whereby the medicine kills and eradicates the bacteria, are also displayed to a lesser extent. Even if the bacteria have mechanisms to counter the antibacterial activities of Tetracycline, Omadacycline’s effectiveness will not be compromised, which makes it superior to other antibacterials.

What Is the Dosage of Omadacycline?

The dosage of Omadacycline differs from the drug formulation. For tablet formulation, the initial dose could be 450 milligrams (mg) a day, while that for intravenous infusion (drug delivered into a vein) is 100 to 200 mg. Similarly, the Omadacycline maintenance dose also tends to differ for tablet and infusion formulations, 100 to 300 mg for infusions and 300 mg for tablets.

How Effective Is Omadacycline?

Omadacycline is an excellent, effective medicine for several bacterial infections, particularly ABSSSI. The main highlight of this medicine is its ability to bypass the bacteria’s drug resistance. Resistance to antibacterial agents is often the most challenging part of dealing with an infection. Drug resistance makes the medication therapy unproductive and ineffective, and the infections become more challenging.

Omadacycline’s potency extends to several bacterial species, including penicillin-resistant Streptococcus pneumonia, methicillin-resistant Staphylococcus aureus, Legionella, beta-hemolytic Streptococci, and Hemophilus influenzae. Omadacycline can subjugate the bacteria's resistance and tolerance to medicines, and resistance to any antibacterial drug could be overpowered by Omadacycline.

What Are the Things to Inform the Doctor Before Taking the Drug?

• Omadacycline Allergy: Allergic reactions encountered with Omadacycline.

• Drug Allergy: Any abnormal reactivity with related drug groups like Demeclocycline, Doxycycline, Tetracycline, Sarecycline, and Minocycline.

• Drug History: All the medicines and off-label medicaments that the person takes.

• Medical History: All the medical conditions, illnesses, or health crises the person has and is having now.

• Pregnancy Plans: No pregnancy plans should be made; discuss with the doctor for appropriate contraception.

• Sun Exposure: Intimate regarding unavoidable sun exposure in case it is part of occupation or daily living.

• Breastfeeding: Intimate if breastfeeding as it needs to be withdrawn.

How Is Omadacycline Administered?

Omadacycline is available in tablet and intravenous formulations. Each formulation requires specific guidelines.

• Omadacycline Tablets: Deliver the pill on an empty stomach; at least fast for four hours. Following this, water fasting (nothing other than water) has to be observed for another two hours post-Omadacycline pill intake.

• Omadacycline Intravenous Infusion: For infusion, Omadacycline in lyophilized powder form has to be made into a solution form; for that sterile water of appropriate quantity can be used to get it prepared. For example, five milliliters of sterile water need to be utilized to get 100 mg of Omadacycline lyophilized powder dissolved. Ideally, the reconstituted solution should give a yellow to deep orange color; if different, get it discarded. The reconstituted Omadacycline of the required amount is then taken from the vial and diluted with saline or dextrose infusion solution.

What Are the Side Effects of Omadacycline?

Side effects of Omadacycline that are often noted include:

• Nausea.

• Constipation.

• Vomiting.

• Headache.

• Diarrhea.

• Trouble sleeping.

• Skin rashes.

• Breathing issues.

• Itching sensation.

• Stomach pain.

• Vision problems.

• Bloody stool.

Dietary Considerations:

Most patients should make small changes in their diet when taking Omadacycline or after taking the Omadacycline pill. If one has taken the pill, then for the next two hours, one cannot consume anything that is diary-based.

Missed Dose:

If any of Omadacycline dose is forgotten, one can take it once the person realizes the miss. However, if the dose missing is realized quite late when the subsequent dose time is almost close, it is better to disregard it and adhere to the further schedule of taking Omadacycline.

Overdose:

Omadacycline, like any other medicine, can also cause overdosing issues. The issue arises when Omadacycline is taken in a dose that is more than the intended dose. Help from the poison control centers or doctors can be reached during Omadacycline overdosing.

Storage:

For Omadacycline tablets, it ought to be between 15 to 30 degrees Celsius (59 to 86 degrees Fahrenheit). For Omadacycline lyophilized powder, it should be in the range of 15 to 30 degrees Celsius (59 to 86 degrees Fahrenheit).For the diluted infusion solution of Omadacycline, two specific storage temperatures are determined with varying shelf life - 24 hours shelf life when kept under 25 degrees Celsius and 48 hours under refrigeration.

For Doctors:

Indications:

• ABSSSI.

• CABP.

Dose:

Concerning the Omadacycline tablet dose,a loading dose of 450 milligrams of Omadacycline is employed for the first two days. Afterward, a daily maintenance dose of 300 milligrams ought to be followed. Two dosing regimens are there for Omadacycline infusion. One suggests a 200-milligram loading dose for the very first day. This is followed by a 100 milligrams maintenance dose. The infusion speed should be modified so that 200 milligrams get infused in 60 minutes time and 100 milligrams in 30 minutes time. The second approach involves receiving a 100-milligram loading dose twice on the first day. Subsequently, there is a 300-milligram oral dosage.

What Are the Pharmacological Aspects of Omadacycline?

• Mechanism of Action: Bacterial protein synthesis is the critical step that Omadacycline could interrupt. It interrupts and breaks off the synthesis of protein by attaching and interacting with the 30s ribosomal subunit. Though it is primarily bacteriostatic, it also possesses certain bactericidal aspects as well. Bacteria with efflux genes or ribosomal protection genes that render antibacterial resistance, particularly against the antibacterial drug group tetracyclines, are also susceptible to Omadacycline. In addition to the above-mentioned genes, the Ciprofloxacin resistance gene and macrolide resistance genes are also vulnerable to Omadacycline action. This peculiar benefit of Omadacycline in overriding the drug resistance that the bacteria have is what that makes it stand out from other antibacterials.

• Pharmacodynamics: The protein synthesis inhibition produced by Omadacycline is way stronger than the inhibition produced by antibacterials of the tetracycline drug group. However, the binding site of the 30s ribosome subunit for both tetracyclines and Omadacyclines are almost the same.

• Pharmacokinetics: Omadacycline oral of 300 mg dose and its infusion form of 100 mg dose both expressed similar exposure, provided the oral form is delivered under a fasting state. Food, particularly dairy products, can bring down the uptake and absorption remarkably. Roughly 20 percent of Omadacycline gets distributed by the interaction with plasma proteins. No apparent metabolism does happen for Omadacycline. Urinary and fecal routes are responsible for Omadacycline clearance, though the major elimination happens through the fecal route.

Toxicity:

Reports of oncogenic activities were highlighted in certain antibacterial medicines, which tend to be closely associated with Omadacycline. Since no specific investigations are being made for Omadacycline, the chance for it to cause any such outcome cannot be overlooked. Meanwhile, in vitro mutagenicity reports were inconclusive and mixed. Heavy Omadacycline doses caused depletion in the fertility potentials when investigated in animals.

Clinical Studies:

Two multicentric, double-dummy, double-blinded, and multinational trials explored Omadacyline’s therapeutics. The trials weighed up the outcome of Omadacycline with that of Linezolid. Cellulitis, major abscesses, and wound infections were the conditions that were chosen for the trial. Both trials revealed that Omadacycline therapy could bring out a better and more appreciable treatment outcome. Early responses with Omadacycline were really encouraging, and the burden of the infection also decreased notably with the initial few doses itself.

What Are the Contraindications of Omadacycline?

Allergies to the tetracycline drug group or Omadacycline, in particular, are the instances where Omadacycline therapy should not be considered.

Warnings and Precautions:

Omadacycline therapy can lead to staining of teeth whenever used by kids within tooth forming age, and that is within eight years of age. It could also elicit tooth discoloration in the baby if taken during the third trimester, which is during late pregnancy.

It is also crucial to get prepared for severe and even critical hypersensitivity issues connected with Omadacycline beforehand in order not to experience serious consequences.

Omadacycline is known to inhibit fetal bone growth when it is given in the later pregnancy stage, which is the third trimester. When used by kids under eight, a similar impact on their bones can be found.However, the inhibition was observed to be reversible in that it disappears once Omadacycline therapy is removed.

As it has been mentioned, Omadacycline belongs to the tetracycline derivative and therefore it possesses certain effects of this class of drugs. They have a greater predisposition to antianabolic actions, pseudotumor cerebri, and photosensitivity.

When the drug Omadacycline is prescribed where its use has not been justified, then it might cause Omadacycline resistance development.

What Are the Drug Interactions of Omadacycline?

Omadacycline tablet, when concurrently delivered with antacid, can mitigate the uptake of Omadacycline. Aluminum, magnesium, and calcium-based antacids are specifically known to deplete the uptake of Omadacycline.

Anticoagulant activities might get exaggerated by Omadacycline. Therefore, when employed simultaneously, anticoagulant dose ought to be turned down such that even if Omadacycline deepenes the anticoagulant effect it could not be turned detrimental.

Iron preparation also mitigates the Omadacycline uptake, and hence monitoring needed for concurrent administration.

Specific Considerations:

Pregnancy: Omadacycline therapy is not advisable for expectant women. Animal studies have underscored the gravity of fetal harm with Omadacycline therapy. Similarly, Omadacycline therapy in the second and third trimesters could possibly cause issues in the fetus’ bone and tooth. Therefore, advocate the patient to take up necessary contraceptions while on Omadacycline therapy.

Breastfeeding: It is best not to advocate Omadacycline to one who is lactating. There is not much information available pertaining to the impact that Omadacycline can have on lactating women and the baby who is being fed by the women. However, tetracyclines have the potency to discharge through the breastmilk, and so the same can be expected with Omadacycline as well considering its structural connection with the tetracycline drug group.

Pediatric Patients: Omadacycline is not perceived to be a pediatric-friendly medicament and, hence, not advisable for them. Its therapeutics for those under 18 years are not explored much and are strictly not advisable.